PhotonPharma
Business Services · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3185 Rampart Rd Ste D230, Fort Collins, ...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About PhotonPharma
PhotonPharma Inc. specializes in developing innovative therapies for solid tumor cancers, with a focus on their product Innocell, an autologous vaccine designed to delay disease progression in patients. The company is currently conducting a Phase 1 clinical study to assess the safety and immunogenicity of Innocell in patients with recurrent epithelial ovarian cancer. Their intended clients are patients aged 18 and older who are facing challenges with this specific type of cancer. PhotonPharma aims to enhance treatment outcomes in conjunction with existing therapies such as chemotherapy, immunotherapy, and surgery.Explore more
PhotonPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PhotonPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once PhotonPharma has new funding data
Product Launch: Get notified when PhotonPharma launches new products
Congratulate Masked Content for being promoted to Masked Content at PhotonPharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if PhotonPharma is spiking on competitors!
Earning: See what the market has to say on PhotonPharma recently announced quarterly report
Check if PhotonPharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if PhotonPharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
PhotonPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at PhotonPharma
Find more new buyers
Compare Similar Companies to PhotonPharma
Compare insights from companies similar to PhotonPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PhotonPharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PhotonPharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PhotonPharma.
PhotonPharma financials insights
Gather financial insights about PhotonPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$2.5M
PhotonPharma Tech Stack
A closer look at the technologies used by PhotonPharma
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Product Management, Medical Research, Pharmaceuticals, Clinical Operations
Project
Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PhotonPharma
Sign Up For FreeTo access detailed company insights
PhotonPharma Inc. specializes in developing innovative therapies for solid tumor cancers, with a focus on their product Innocell, an autologous vaccine designed to delay disease progression in patients. The company is currently conducting a Phase 1 clinical study to assess the safety and immunogenicity of Innocell in patients with recurrent epithel... Read More
